Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript

GERON CORP (GERN) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 8-K Quarterly results
08/22/2023 8-K Other Events  Interactive Data
08/03/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "### 7"
06/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CERTIFICATE OF AMENDMENTOF THE RESTATED CERTIFICATE OF INCORPORATION OF GERON CORPORATION,",
"Successor to and Continuation of Prior Plans. The Plan is intended as the successor to and continuation of the Geron Corporation 2011 Incentive Award Plan and the Geron Corporation 1992 Stock Option Plan , the Geron Corporation 1996 Directors’ Stock Option Plan and the Geron Corporation Amended and Restated 2002 Equity Incentive Plan . Following the Effective Date, no additional stock awards may be granted under the Prior Plans. Any unallocated shares remaining available for grant under the Prior Plans as of 12:01 a.m., Pacific Time on the Effective Date will cease to be available under the Prior Plans at such time and will be added to the Share Reserve below) and be then immediately available for grant and issuance pursuant to Stock Awards granted under the Plan. In addition, from and aft..."
05/11/2023 8-K Quarterly results
Docs: "### 5"
04/20/2023 8-K Quarterly results
03/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "NOTICE OF PENDENCY OF SETTLEMENT OF DERIVATIVE LITIGATION"
03/16/2023 8-K Quarterly results
Docs: "###"
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
02/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/06/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNDERWRITING AGREEMENT",
"FORM OF PRE-FUNDED WARRANT",
"OPINION OF COOLEY LLP"
01/04/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UPDATED COMPANY DISCLOSURE"
12/22/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "STIPULATION OF SETTLEMENT"
11/03/2022 8-K Quarterly results
09/08/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/06/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "STIPULATION AND AGREEMENT OF SETTLEMENT, DATED SEP 2, 2022"
08/11/2022 8-K Quarterly results
06/30/2022 8-K Quarterly results
06/15/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
04/13/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "21ST ANNUAL NEEDHAM VIRTUAL HEALTHCARE"
03/30/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "GERON CORPORATION 53,333,334 Shares of Common Stock Pre-Funded Warrants to Purchase up to 18,095,238 Shares of Common Stock Common Warrants to Purchase up to 35,714,286 Shares of Common Stock UNDERWRITING AGREEMENT",
"Geron Corporation, a Delaware corporation , up to shares of the Company’s common stock, par value $0.001 per share . The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is one of the Pre-Funded Common Stock Purchase Warrants issued in connection with the transactions contemplated by that certain Underwriting Agreement, dated as of , 2022, by and between the Company and Stifel, Nicolaus & Company, Incorporated and Robert W. Baird & Co. Incorporated, as the representatives of the several underwriters named therein, the Company’s Registration Statement on Form S-3 and the Company’s prospectus supplement dated , 2022 to the base prospectus (the “Prospectus Supplement",
"Geron Corporation, a Delaware corporation , up to shares of the Company’s common stock, par value $0.001 per share . The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is one of the Common Stock Purchase Warrants issued in connection with the transactions contemplated by that certain Underwriting Agreement, dated as of , 2022, by and between the Company and Stifel, Nicolaus & Company, Incorporated and Robert W. Baird & Co. Incorporated, as the representatives of the several underwriters named therein, the Company’s Registration Statement on Form S-3 and the Company’s prospectus supplement dated , 2022 to the base prospectus (the “Prospectus Supplement",
"919 East Hillsdale Boulevard, Suite 250 Foster City, California 94404"
03/10/2022 8-K Quarterly results
Docs: "Press Release Dated March 10, 2022 Geron Corporation Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Milestones"
02/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/10/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "JANUARY 2022 CORPORATE PRESENTATION SLIDES"
12/02/2021 8-K Quarterly results
08/16/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Press Release Dated August 16, 2021 Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023"
05/14/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
05/10/2021 8-K Quarterly results
03/11/2021 8-K Quarterly results
02/05/2021 8-K Quarterly results
01/08/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy